All books
Testosterone in Women

Fady Hannah-Shmouni, MD, FRCPC, ABIM

Testosterone in Women

Pellets, injections, creams, gels, vaginal and beyond — the evidence, the formulations, and the law · First edition · 2026

$14.00793 pages • PDF • Free sample available
A 793-page English evidence monograph for licensed clinicians on testosterone therapy in women. Covers female androgen physiology, measurement and diagnosis, HSDD, formulations and routes, trial evidence, safety, monitoring, special populations, international regulation and informed consent. The interactive PDF includes a visual atlas, clickable algorithms, a clinical case-finder matrix and fillable consultation checklists. Educational content and a reference for clinical reasoning—not individual medical advice or a protocol for unapproved use.

Instant PDF download after payment

About this monograph

A separate 793-page first-edition English reference focused on testosterone in women. The 2026 monograph covers physiology, diagnosis, formulations, evidence, safety, special populations and regulation.

The interactive PDF includes a visual atlas and clickable algorithms, a clinical case-finder matrix and fillable consultation checklists. Its contents distinguish approved, off-label and compounded routes.

Educational content for licensed clinicians, not individual medical advice or a protocol for unapproved use. Verify current product labeling, guidelines and local requirements.

What you'll learn

  • Female androgen physiology, laboratory measurement and clinical assessment
  • HSDD, guideline comparisons and limits of the evidence
  • Transdermal, pellet, injectable, vaginal and other formulations
  • Safety, monitoring, interactions and special populations
  • International regulation, informed consent and medicolegal considerations

Who it's for

  • Licensed clinicians reviewing testosterone therapy in women
  • Clinical educators and researchers examining the evidence

What's inside

  1. 1Foundations: female androgen physiology, lifespan, measurement and lab interpretation
  2. 2Diagnosis: HSDD, androgen insufficiency, contraindications and guidelines
  3. 3Formulations: transdermal, pellets, injections, vaginal and other routes
  4. 4DHEA, prasterone, tibolone and compounded testosterone
  5. 5Evidence and safety: HSDD trials, other uses, monitoring and interactions
  6. 6Special populations and hormone-sensitive conditions
  7. 7Regulation, pellet clinics, telehealth, informed consent and medicolegal considerations
  8. 8Clinical cases and consultation tools
  9. 9Interactive atlas and clickable algorithms
  10. 10Appendices: key trials, unit conversions and abbreviations

Preview

Free sample
Your browser can't display the PDF inline. Open the sample in a new tab

This is a free preview. Purchase the book above to download the full PDF.

You may also like